Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Acta Otolaryngol ; 143(4): 346-351, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37067345

RESUMEN

BACKGROUND: Necessity of new and alternative treatments in traumatic facial nerve injury. AIMS/OBJECTIVE: In this experimental study, we aimed to evaluate the histopathologic and functional effects of methylprednisolone, hyperbaric oxygen and hesperidin + diosmin treatments on traumatic facial nerve regeneration in rats. METHODS: After facial nerve injury, five groups were formed with eight rats in each group: Group 1 (negative control), 2 (operation), 3 (corticosteroid), 4 (hyperbaric oxygen), 5 (hesperidin + diosmin). Blink reflex of rats evaluated a day after the operation and at the first, second and third weeks. Facial nerve samples from sacrificed animals were examined under a light microscope. RESULTS: According to our results, in group 4; axonal degeneration and vascular congestion were significantly lower than group 2 and 3, and myelin sheath thickness was significantly higher than group 3. In group 5; axonal degeneration was significantly lower than group 2 and vascular congestion was significantly lower than group 2 and 3. In terms of functional recovery; there was no statistically significant difference between the groups. CONCLUSIONS AND SIGNIFICANCE: It has been shown that both hyperbaric oxygen and hesperidin + diosmin treatments have positive effects on facial nerve regeneration. Both treatments may be good alternatives for ameliorating traumatic nerve injury, but these treatment modalities need to be further explored.


Asunto(s)
Diosmina , Traumatismos del Nervio Facial , Hesperidina , Oxigenoterapia Hiperbárica , Ratas , Animales , Metilprednisolona/farmacología , Hesperidina/farmacología , Diosmina/farmacología , Modelos Animales , Nervio Facial/patología , Regeneración Nerviosa
2.
Acta Otolaryngol ; 141(11): 989-993, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34694199

RESUMEN

BACKGROUND: The effect of Covid-19 infection on nasal mucociliary clearance (MCC) is unknown. AIMS/OBJECTIVES: The aim of this study is to investigate the relationship between Covid-19 and nasal MCC in terms of smoking, Covid-19 symptoms and treatment. METHODS: Thirty-six patients who were hospitalized in the pandemic ward due to Covid-19 and 36 volunteers (Covid-19 negative test result) who presented to the otolaryngology outpatient clinic with non-nasal symptoms were included in this study. The Saccharin test was performed in both groups to evaluate nasal MCC. RESULTS: The patients and control groups were not significantly different in terms of age and gender. The nasal MCC time was significantly higher in the patient group compared to the control group (19.18 ± 10.84 min and 13.78 ± 8.18 min, p = .003). CONCLUSIONS AND SIGNIFICANCE: In this study, we found that Covid-19 prolonged nasal MCC time regardless of age. We suggest that corticosteroids should be included in the treatment of Covid-19, both with its symptom reduction and its positive effect on MCC duration.


Asunto(s)
COVID-19/fisiopatología , Depuración Mucociliar/fisiología , Mucosa Nasal/fisiopatología , Fumar/fisiopatología , Corticoesteroides/farmacología , Corticoesteroides/uso terapéutico , Adulto , Amidas/uso terapéutico , Antivirales/uso terapéutico , COVID-19/complicaciones , Estudios de Casos y Controles , Femenino , Humanos , Hidroxicloroquina/efectos adversos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Depuración Mucociliar/efectos de los fármacos , Pirazinas/uso terapéutico , Tratamiento Farmacológico de COVID-19
3.
J Audiol Otol ; 24(3): 127-132, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32397013

RESUMEN

BACKGROUND AND OBJECTIVES: In this study, we compared the outcomes of patients with idiopathic sudden sensorineural hearing loss who underwent steroid treatment with or without hyperbaric oxygen (HBO) therapy and were followed-up in our clinic. SUBJECTS AND METHODS: Patients were divided into two groups according to their treatment regimen. Steroid group received intravenous 1 mg/kg methylprednisolone which was due to be completed in 2-3 weeks with decreasing doses, and five doses of 0.5 mL intratympanic dexamethasone. Steroid+HBO group received the same steroid treatment with the addition of HBO therapy. The audiologic results of both treatment groups were compared after considering the patients' risk factors. RESULTS: There was no significant difference between the steroid and Steroid+HBO groups in terms of hearing gain and degree of recovery, both at all degrees of hearing loss, and in severe and profound hearing loss. Hearing gain was similar when evaluated by audiogram type and admission time in both treatment groups. CONCLUSIONS: We found that the addition of HBO therapy to systemic plus intratympanic steroid treatment did not affect hearing gain at all degrees of hearing loss in this study. Furthermore, audiogram type and admission time did not affect hearing gain between the two groups.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA